19 Recruiting Glioblastoma Multiforme Phase 1 Clinical Trials
Active phase 1 studies for glioblastoma multiforme enrolling across the USA. Verify eligibility and contact site coordinators.
All Glioblastoma Multiforme studiesPhase 1 Studies for Glioblastoma Multiforme
Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
📍 Barrow Brain and Spine — Phoenix, Arizona
View Study & Checklist ➔Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
📍 Stanford University — Stanford, California
View Study & Checklist ➔A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)
📍 Research Site — Los Angeles, California
View Study & Checklist ➔Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
📍 University of Southern California — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
📍 University of California, Los Angeles — Los Angeles, California
View Study & Checklist ➔NG101m Adjuvant Therapy in Glioblastoma Patients
📍 Yvonne Kew MD, PLLC — Houston, Texas
View Study & Checklist ➔Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
📍 Lenox Hill Brain Tumor Center — New York, New York
View Study & Checklist ➔Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
📍 University of California at Los Angeles — Los Angeles, California
View Study & Checklist ➔HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
📍 Houston Methodist Neurological Institute — Houston, Texas
View Study & Checklist ➔Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
📍 Johns Hopkins Medical Institution — Baltimore, Maryland
View Study & Checklist ➔Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
📍 University of Florida Health — Gainesville, Florida
View Study & Checklist ➔Study of Pembrolizumab and M032 (NSC 733972)
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
📍 Stony Brook University Hospital — Stony Brook, New York
View Study & Checklist ➔IA Carboplatin + Radiotherapy in Relapsing GBM
📍 CHUS — Sherbrooke, Quebec
View Study & Checklist ➔Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
📍 Jackson Memorial Hospital — Miami, Florida
View Study & Checklist ➔A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
📍 University of Alabama Birmingham — Birmingham, Alabama
View Study & Checklist ➔